Developer docs
API playgroundTry for free, no card

Search company profiles

Envetec

Full company profile

uuid00031vu

Namestring
Envetec
Legal namestring
Envetec Sustainable Technologies
Websiteurl
envetec.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Envetec Sustainable Technologies is an Irish clean-technology company founded in 2021 and headquartered in County Tipperary, Ireland. It has developed GENERATIONS, an on-site, non-thermal biohazardous waste treatment system that uses mechanical shredding combined with a proprietary organic biodegradable disinfectant (Vigor-Ox, a peracetic-acid and hydrogen-peroxide formula validated at 1–3% concentration and US EPA approved) to disinfect regulated medical and laboratory waste. The system achieves 6-log10 pathogen reduction (STAATT IV) — 100× more efficient than the standard STAATT III baseline — and uniquely preserves polymer integrity so that treated plastics can be recycled into manufacturing feedstock rather than landfilled or incinerated. An in-built validation chamber verifies treatment efficacy live during operation without process downtime.

The company sells GENERATIONS hardware under multi-year enterprise contracts to life-sciences customers in five verticals: healthcare, pharmaceutical and biopharma, medical device, food and beverage, and veterinary. Pricing is custom-quoted based on facility size and waste volume, with no publicly disclosed price list. Revenue also includes ongoing technical support, validation, and regulatory-compliance services. Distribution is direct enterprise field sales only, with no channel partners. GENERATIONS Connect, launched with Siemens in February 2026, adds a digital monitoring and connectivity layer to the installed base.

Named enterprise customers include Northwell Health (the largest health system in New York State), BD (Becton, Dickinson and Company, with whom Envetec completed a closed-loop recycling feasibility study in January 2026 for polystyrene Petri dishes), and Dairygold (an Irish agricultural cooperative). Regulatory approvals span the US EPA, New York State Department of Health, Massachusetts, and the UK Environment Agency, supplemented by ISO 14064-1 greenhouse gas quantification and My Green Lab ACT labels in Europe, the UK, and the US. The company is privately held, has raised approximately $10.7M in equity funding (May 2022, investors undisclosed), and employs 11–50 people.

Short descriptiontext

Envetec is an Irish clean-technology company that sells the GENERATIONS non-thermal, on-site biohazardous waste treatment system to healthcare, pharmaceutical, medical device, food and beverage, and veterinary facilities, enabling recycling of treated plastics into manufacturing feedstock.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBirdhill, Ireland
HQ citystring
Birdhill
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biohazardous waste treatment, medical waste recycling, non-thermal disinfection, life sciences sustainability, plastic circular economy
Industry2 codes
PRIMARYBPALAHAE
Chemical Waste Incineration & Thermal Treatment
SECONDARYEUAIAJAC
End-of-Life Vehicle (ELV) Dismantling & Depollution (Fluids, Batteries, Airbags)
NAICS code2 codes
  • Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing33341
  • Urethane and Other Foam Product (except Polystyrene) Manufacturing32615
Product category
Medical Waste Treatment Equipment
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1GENERATIONS System Sales
TypeOne Time License
Description

Sale and installation of GENERATIONS equipment to life sciences facilities. Equipment pricing based on facility size and waste volume requirements. Includes preliminary testing of customer waste streams for suitability verification.

envetec.com
2Technical Support Services
TypeProfessional Services
Description

Ongoing technical support and product-related customer feedback services. Includes validation support and regulatory compliance assistance for different jurisdictions.

envetec.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise equipment sale - custom pricing based on facility requirements
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing available. Sales process involves contact form submission and technical team evaluation for site-specific requirements and custom proposals.

envetec.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1GENERATIONS
Description

On-site, non-thermal clean technology that treats biohazardous waste and enables plastic recycling. The technology uses a proprietary organic biodegradable disinfectant (Vigor-Ox) and mechanical shredding to achieve STAATT IV level decontamination while preserving polymer properties for recycling.

envetec.com
Core offering1 text field

Envetec designs, manufactures, and sells the GENERATIONS system, an on-site non-thermal clean-technology platform that mechanically shreds and chemically disinfects biohazardous waste (regulated medical waste, laboratory plastics, sharps) using its proprietary Vigor-Ox disinfectant. The treated output is converted into recyclable polymer flakes that can be reintroduced into manufacturing supply chains, eliminating the carbon-intensive transport and thermal treatment steps traditionally used by life sciences organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 90% reduction in biohazard waste disposal related emissions on average
+5 more records
Product overview1 text field

Envetec offers a single unified product called GENERATIONS, an on-site non-thermal clean technology system for biohazardous waste treatment. The product converts biohazardous waste into disinfected, recyclable polymer flakes suitable for reintroduction into manufacturing supply chains. An add-on module called GENERATIONS Connect provides monitoring and data connectivity. The system serves life science industries including healthcare, pharmaceutical, medical device, food and beverage, and veterinary sectors.

Product and service2 records
1GENERATIONS
2GENERATIONS Connect
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-01
Description

Partnership with Siemens for GENERATIONS Connect platform, integrating digital connectivity and operational monitoring capabilities into the GENERATIONS system.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Joint feasibility study demonstrating closed-loop recycling solution for laboratory plastics in healthcare. Successfully processed BD BBL prepared plated media through Envetec's GENERATIONS technology, converting plastics into polymer flakes extruded into pellets and molded into new Petri dish prototypes. Both companies plan to expand the pilot and develop circular economy pathways for other high-volume healthcare consumables.

Strategic tierMinorTypeOthers
Description

My Green Lab provided independent ACT label certification for GENERATIONS technology in Europe, UK, and US markets, acknowledging innovation in biohazardous waste treatment.

4Carbon Action
Strategic tierMinorTypeOthers
Description

Independent London-based carbon consultancy firm that performed eight separate evaluations validating GENERATIONS carbon reduction capabilities across sites in US, UK, and Ireland.

envetec.com
Strategic tierMinorTypeOthers
Description

Industry consortium where Envetec participates in cross-value-chain collaboration to overcome systemic barriers in healthcare plastics recycling. HPRC Spring 2026 Full Council Meeting featured Envetec/BD feasibility study.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Largest dedicated regulated medical waste management company in North America, offering collection, transport, and treatment (autoclave and incineration) services. Overlaps with Envetec's healthcare and life sciences customer base while representing the dominant incumbent whose infrastructure Envetec is positioning to displace.

TypeBroad incumbent
Description

North American provider of hazardous and industrial waste management, including regulated medical waste services for healthcare and life sciences. Comparable in serving the same end markets and addressing regulated chemical/biohazardous waste streams, though with a portfolio approach rather than a single on-site solution.

TypeBroad incumbent
Description

Bio-decontamination technology provider (now part of Ecolab) using hydrogen peroxide vapor for life sciences, healthcare, and pharmaceutical facilities. Comparable in offering non-thermal, chemistry-based disinfection systems to the same regulated life sciences customers, though focused on room/equipment decontamination rather than waste treatment.

TypeRegional player
Description

US medical waste disposal provider serving hospitals, clinics, and labs with regulated waste collection and treatment. Comparable in addressing healthcare biohazardous waste with a service-led model, though primarily US-focused and reliant on traditional disposal methods rather than on-site non-thermal treatment.

TypeBroad incumbent
Description

Global environmental services group with a healthcare waste treatment division serving hospitals and life sciences customers across Europe and beyond. Comparable as a large-scale provider of medical waste processing with broader waste management capabilities that Envetec competes against for sustainability-focused enterprise customers.

TypeRegional player
Description

US-focused provider of medical, pharmaceutical, and hazardous waste management services to small and mid-quantity generators including hospitals and labs. Comparable in targeting healthcare biohazardous waste with mail-back and pickup solutions, with a primarily US geographic footprint similar to Envetec's largest disclosed market.

TypeEmerging player
Description

Provider of proprietary non-thermal disinfection and decontamination technology (SteraMist) for life sciences, healthcare, and public spaces. Comparable as an emerging technology company offering an alternative to thermal sterilization methods, intersecting with Envetec's non-thermal disinfection value proposition.

TypeDirect peer
Description

Provider of medical and sharps waste management solutions, including reusable containment and on-site treatment programs for hospitals and labs. Directly comparable to Envetec in targeting healthcare biohazardous waste with sustainability-oriented alternatives to incineration and off-site disposal.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Envetec

Medical Waste Treatment Equipmentenvetec.com

Envetec is an Irish clean-technology company that sells the GENERATIONS non-thermal, on-site biohazardous waste treatment system to healthcare, pharmaceutical, medical device, food and beverage, and veterinary facilities, enabling recycling of treated plastics into manufacturing feedstock.

What Envetec does

Envetec Sustainable Technologies is an Irish clean-technology company founded in 2021 and headquartered in County Tipperary, Ireland. It has developed GENERATIONS, an on-site, non-thermal biohazardous waste treatment system that uses mechanical shredding combined with a proprietary organic biodegradable disinfectant (Vigor-Ox, a peracetic-acid and hydrogen-peroxide formula validated at 1–3% concentration and US EPA approved) to disinfect regulated medical and laboratory waste. The system achieves 6-log10 pathogen reduction (STAATT IV) — 100× more efficient than the standard STAATT III baseline — and uniquely preserves polymer integrity so that treated plastics can be recycled into manufacturing feedstock rather than landfilled or incinerated. An in-built validation chamber verifies treatment efficacy live during operation without process downtime.

The company sells GENERATIONS hardware under multi-year enterprise contracts to life-sciences customers in five verticals: healthcare, pharmaceutical and biopharma, medical device, food and beverage, and veterinary. Pricing is custom-quoted based on facility size and waste volume, with no publicly disclosed price list. Revenue also includes ongoing technical support, validation, and regulatory-compliance services. Distribution is direct enterprise field sales only, with no channel partners. GENERATIONS Connect, launched with Siemens in February 2026, adds a digital monitoring and connectivity layer to the installed base.

Named enterprise customers include Northwell Health (the largest health system in New York State), BD (Becton, Dickinson and Company, with whom Envetec completed a closed-loop recycling feasibility study in January 2026 for polystyrene Petri dishes), and Dairygold (an Irish agricultural cooperative). Regulatory approvals span the US EPA, New York State Department of Health, Massachusetts, and the UK Environment Agency, supplemented by ISO 14064-1 greenhouse gas quantification and My Green Lab ACT labels in Europe, the UK, and the US. The company is privately held, has raised approximately $10.7M in equity funding (May 2022, investors undisclosed), and employs 11–50 people.

Envetec firmographics

Firmographics
Name
Envetec
Legal name
Envetec Sustainable Technologies
Website
https://envetec.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Envetec is an Irish clean-technology company that sells the GENERATIONS non-thermal, on-site biohazardous waste treatment system to healthcare, pharmaceutical, medical device, food and beverage, and veterinary facilities, enabling recycling of treated plastics into manufacturing feedstock.
Ownership category
akta.pro rank

Envetec industry classification

Industry
Product category
Medical Waste Treatment Equipment
NAICS
Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing (33341), Urethane and Other Foam Product (except Polystyrene) Manufacturing (32615)
akta.pro industry
PRIMARYBPALAHAE
Chemical Waste Incineration & Thermal Treatment
SECONDARYEUAIAJAC
End-of-Life Vehicle (ELV) Dismantling & Depollution (Fluids, Batteries, Airbags)

Keywords

  • Biohazardous waste treatment
  • Medical waste recycling
  • Non-thermal disinfection
  • Life sciences sustainability
  • Plastic circular economy

Where Envetec is headquartered

Location

Headquarters

HQ city
Birdhill
HQ country
Ireland
HQ region
Europe

Offices1 record

Markets served

Envetec business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. GENERATIONS System Sales: Sale and installation of GENERATIONS equipment to life sciences facilities. Equipment pricing based on facility size and waste volume requirements. Includes preliminary testing of customer waste streams for suitability verification.
  2. Technical Support Services: Ongoing technical support and product-related customer feedback services. Includes validation support and regulatory compliance assistance for different jurisdictions.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise equipment sale - custom pricing based on facility requirements

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Envetec product offering

Product offering

Core offering

Envetec designs, manufactures, and sells the GENERATIONS system, an on-site non-thermal clean-technology platform that mechanically shreds and chemically disinfects biohazardous waste (regulated medical waste, laboratory plastics, sharps) using its proprietary Vigor-Ox disinfectant. The treated output is converted into recyclable polymer flakes that can be reintroduced into manufacturing supply chains, eliminating the carbon-intensive transport and thermal treatment steps traditionally used by life sciences organizations.

Product overview

Envetec offers a single unified product called GENERATIONS, an on-site non-thermal clean technology system for biohazardous waste treatment. The product converts biohazardous waste into disinfected, recyclable polymer flakes suitable for reintroduction into manufacturing supply chains. An add-on module called GENERATIONS Connect provides monitoring and data connectivity. The system serves life science industries including healthcare, pharmaceutical, medical device, food and beverage, and veterinary sectors.

Differentiator

Problem solved

Functional benefit

Brands

  • GENERATIONS: On-site, non-thermal clean technology that treats biohazardous waste and enables plastic recycling. The technology uses a proprietary organic biodegradable disinfectant (Vigor-Ox) and mechanical shredding to achieve STAATT IV level decontamination while preserving polymer properties for recycling.

Products and services

  • GENERATIONS
  • GENERATIONS Connect

Quantifiable outcome

  • 90% reduction in biohazard waste disposal related emissions on average
  • +5 more outcomes

Companies that use Envetec

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Envetec technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Envetec partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • SiemenscoreTechnology or Integration · 1 February 2026Partnership with Siemens for GENERATIONS Connect platform, integrating digital connectivity and operational monitoring capabilities into the GENERATIONS system.
  • BD (Becton, Dickinson and Company)coreStrategic or Co-development Partner · 1 January 2026Joint feasibility study demonstrating closed-loop recycling solution for laboratory plastics in healthcare. Successfully processed BD BBL prepared plated media through Envetec's GENERATIONS technology, converting plastics into polymer flakes extruded into pellets and molded into new Petri dish prototypes. Both companies plan to expand the pilot and develop circular economy pathways for other high-volume healthcare consumables.
  • My Green LabminorOthersMy Green Lab provided independent ACT label certification for GENERATIONS technology in Europe, UK, and US markets, acknowledging innovation in biohazardous waste treatment.
  • Carbon ActionminorOthersIndependent London-based carbon consultancy firm that performed eight separate evaluations validating GENERATIONS carbon reduction capabilities across sites in US, UK, and Ireland.
  • Healthcare Plastics Recycling Council (HPRC)minorOthersIndustry consortium where Envetec participates in cross-value-chain collaboration to overcome systemic barriers in healthcare plastics recycling. HPRC Spring 2026 Full Council Meeting featured Envetec/BD feasibility study.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Envetec competitors and assessment

Company assessment

Broad incumbents

  • Stericycle: Largest dedicated regulated medical waste management company in North America, offering collection, transport, and treatment (autoclave and incineration) services. Overlaps with Envetec's healthcare and life sciences customer base while representing the dominant incumbent whose infrastructure Envetec is positioning to displace.
  • Clean Harbors: North American provider of hazardous and industrial waste management, including regulated medical waste services for healthcare and life sciences. Comparable in serving the same end markets and addressing regulated chemical/biohazardous waste streams, though with a portfolio approach rather than a single on-site solution.
  • Bioquell (Ecolab): Bio-decontamination technology provider (now part of Ecolab) using hydrogen peroxide vapor for life sciences, healthcare, and pharmaceutical facilities. Comparable in offering non-thermal, chemistry-based disinfection systems to the same regulated life sciences customers, though focused on room/equipment decontamination rather than waste treatment.
  • Veolia Environmental Services: Global environmental services group with a healthcare waste treatment division serving hospitals and life sciences customers across Europe and beyond. Comparable as a large-scale provider of medical waste processing with broader waste management capabilities that Envetec competes against for sustainability-focused enterprise customers.

Regional players

  • MedPro Disposal: US medical waste disposal provider serving hospitals, clinics, and labs with regulated waste collection and treatment. Comparable in addressing healthcare biohazardous waste with a service-led model, though primarily US-focused and reliant on traditional disposal methods rather than on-site non-thermal treatment.
  • Sharps Compliance: US-focused provider of medical, pharmaceutical, and hazardous waste management services to small and mid-quantity generators including hospitals and labs. Comparable in targeting healthcare biohazardous waste with mail-back and pickup solutions, with a primarily US geographic footprint similar to Envetec's largest disclosed market.

Emerging players

  • TOMI Environmental Solutions (SteraMist): Provider of proprietary non-thermal disinfection and decontamination technology (SteraMist) for life sciences, healthcare, and public spaces. Comparable as an emerging technology company offering an alternative to thermal sterilization methods, intersecting with Envetec's non-thermal disinfection value proposition.

Direct peers

  • Daniels Health: Provider of medical and sharps waste management solutions, including reusable containment and on-site treatment programs for hospitals and labs. Directly comparable to Envetec in targeting healthcare biohazardous waste with sustainability-oriented alternatives to incineration and off-site disposal.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Envetec social profiles

Digital presence

Envetec compliance and trust

Trust signal

Compliance5 records

Envetec financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Envetec leadership team

Management profile

Number of profiles

Profiles4 records

Envetec funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Envetec M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Envetec

What does Envetec do?

Envetec designs, manufactures, and sells the GENERATIONS system, an on-site non-thermal clean-technology platform that mechanically shreds and chemically disinfects biohazardous waste (regulated medical waste, laboratory plastics, sharps) using its proprietary Vigor-Ox disinfectant. The treated output is converted into recyclable polymer flakes that can be reintroduced into manufacturing supply chains, eliminating the carbon-intensive transport and thermal treatment steps traditionally used by life sciences organizations.

Is Envetec a public or private company?

Envetec is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Envetec founded?

Envetec was founded in 2021. It employs 11 to 50 people.

Where is Envetec based?

Envetec is headquartered in Birdhill, Ireland, in the Europe region.

How does Envetec make money?

Two revenue lines are on record. GENERATIONS System Sales are the primary driver. The others are technical Support Services.

Who are Envetec's main competitors?

Broad incumbents on record are Stericycle, Clean Harbors, Bioquell (Ecolab) and Veolia Environmental Services. Regional players are MedPro Disposal and Sharps Compliance. TOMI Environmental Solutions (SteraMist) is listed as an emerging player. Daniels Health is listed as a direct peer.

Does Envetec have an API?

No public API is recorded for Envetec.

What industry is Envetec in?

Envetec's product category is Medical Waste Treatment Equipment. Its primary akta.pro industry code is BPALAHAE, Chemical Waste Incineration & Thermal Treatment, with a secondary code of EUAIAJAC, End-of-Life Vehicle (ELV) Dismantling & Depollution (Fluids, Batteries, Airbags). Its NAICS code is 33341.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Times of IndiaScotland recycles 72,000 contaminated single-use plastic bottles in a world-first move as new technology targets Petri dishes and pipette tipsScottish Water has become the first utility globally to adopt Envetec Sustainable Technologies' GENERATIONS system, which disinfects and shreds contaminated laboratory plastics on-site. The technology has already processed approximately 72,000 sample bottles since January 2026, with plans to expand treatment to Petri dishes and pipette tips. This initiative aims to reduce reliance on traditional disposal methods like incineration and landfill while improving waste traceability.Think BusinessTipp firm lands deal with Scottish WaterScottish Water became the first utility to adopt Envetec's Generations technology to recycle laboratory plastics, processing about 72,000 sample bottles since January. The system treats microbiologically contaminated plastics on site, reducing landfill and incineration. Scottish Water plans to use the data to explore broader deployment across additional waste streams.RecyclingtodayEnvetec receives California approval for medical waste treatment technologyEnvetec Sustainable Technologies has received approval from the California Department of Public Health for its Generations medical waste treatment technology. This regulatory milestone adds California to Envetec's U.S. footprint, following previous approvals in New York, Texas, and Massachusetts, thereby expanding its market reach for healthcare organizations. The nonthermal process reportedly reduces waste-processing emissions by nearly 93 percent and water use by 80.6 percent compared to traditional thermal methods.YahooEnvetec Appoints Patrick S. Jones as Independent DirectorEnvetec Sustainable Technologies Limited has appointed Patrick S. Jones, President of Thermo Fisher Scientific's Clinical Diagnostics Division, as an independent director to its board. This appointment is part of Envetec's strategy to strengthen its global healthcare and commercial expertise as it expands its GENERATIONS® technology in the market. The company is also increasing its regulatory and commercial presence in the United States, aiming to transform waste management in healthcare.ChaindrugreviewSustainable pharmaceutical packaging market to top $270 billion by 2031The global sustainable pharmaceutical packaging market is projected to grow from $114.5 billion in 2025 to $270.4 billion by 2031, reflecting a compound annual growth rate of 15.4%, according to a Wissen Research report. Key growth drivers include stricter environmental regulations, pharmaceutical ESG commitments, expanding pharmaceutical production, and rising consumer demand for sustainable healthcare products. Recent industry partnerships, including Amcor's merger with Berry Global and Becton Dickinson's closed-loop recycling study with Envetec, underscore accelerating investment in circular economy initiatives.PR NewswireSustainable Pharmaceutical Packaging Market to reach USD 270.4 billion by 2031, Wissen ResearchWissen Research published a study projecting the global sustainable pharmaceutical packaging market to nearly double from USD 114.5 billion in 2025 to USD 270.4 billion by 2031, registering a 15.4% CAGR. The market growth is driven by tightening environmental regulations, pharmaceutical companies' ESG commitments, and advances in recyclable mono-materials, bio-based polymers, and smart packaging technologies. Recent strategic developments include Amcor plc's merger with Berry Global Group Inc in April 2026 and Becton, Dickinson and Company's closed-loop recycling partnership with Envetec Sustainable Technologies in January 2026.PR NewswireSustainable Pharmaceutical Packaging Market to reach USD 270.4 billion by 2031, Wissen ResearchWissen Research projects the global sustainable pharmaceutical packaging market to grow from USD 114.5 billion in 2025 to USD 270.4 billion by 2031, representing a 15.4% CAGR, driven by environmental regulations, ESG commitments, and advances in recyclable and bio-based materials. In notable strategic developments, Amcor plc and Berry Global Group Inc merged in April 2026 to strengthen global healthcare packaging capabilities, while Becton, Dickinson and Company partnered with Envetec Sustainable Technologies in January 2026 to advance closed-loop recycling of healthcare plastics. The Asia-Pacific region is expected to record the fastest growth, fueled by increased pharmaceutical production in China, India, and Japan.MoomooSustainable Pharmaceutical Packaging Market to Reach USD 270.4 Billion by 2031, Wissen ResearchAccording to a new study by Wissen Research, the global sustainable pharmaceutical packaging market is projected to expand from USD 114.5 billion in 2025 to USD 270.4 billion by 2031, registering a CAGR of 15.4% during the forecast period. The growth is driven by increasing environmental concerns, stringent pharmaceutical packaging regulations, and corporate sustainability commitments, with advances in material science and circular economy initiatives accelerating the transition to eco-friendly packaging. Notable recent strategic developments include Amcor plc's merger with Berry Global Group Inc. in April 2026 and Becton, Dickinson and Company's closed-loop recycling feasibility study with Envetec Sustainable Technologies in January 2026.Healthcare PackagingCollaboration Is the Cornerstone of Healthcare Plastics Recycling ProgressThe Healthcare Plastics Recycling Council (HPRC) held its Spring 2026 Full Council Meeting, where stakeholders emphasized that cross-value-chain collaboration is essential to overcoming systemic barriers in healthcare plastics recycling. A key highlight was a feasibility study partnership between medical device manufacturer BD and cleantech company Envetec, demonstrating that polystyrene and other medical plastics can be safely disinfected and recycled into high-quality manufacturing feedstock in a closed-loop system. The article outlines HPRC's 2026 project work, including regional recycling initiatives in Houston, resource refreshes for healthcare facilities, recycling infrastructure mapping, standardized labeling guidelines, and a volume-and-value predictive tool.PR NewswireBD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health CareBD (Becton, Dickinson and Company) and Envetec Sustainable Technologies completed a joint feasibility study demonstrating that polystyrene Petri dishes and other laboratory plastics can be recycled into high-quality manufacturing feedstock for new medical products. The pilot successfully processed BD BBL prepared plated media through Envetec's GENERATIONS technology, which chemically disinfected and converted the plastics into polymer flakes that were extruded into pellets and molded into new Petri dish prototypes. Both companies plan to expand the pilot and develop circular economy pathways for other high-volume healthcare consumables to reduce reliance on virgin plastic and keep materials in circulation.